|
- Identify biomarkers that are associated with specific cancer types.
- Target treatments selectively to cancer cells based on biomarker expression.
- Identify and treat only patients who express the biomarkers and are therefore most likely to benefit from treatment.
- Monitor response to treatment by detecting presence/absence of CTCs expressing the biomarkers.
|
